Participants 362 581 7
Four hundred sixty-nine assessable advanced cancer patients were randomized to (1) oral megestrol acetate 800 mg/d liquid suspension plus placebo, (2) oral dronabinol 2.5 mg twice a day plus placebo, or (3) both agents.
Participants 582 782 3
Eligible patients acknowledged that loss of appetite or weight was a problem and reported the loss of 5 pounds or more during 2 months and/or a daily intake of less than 20 calories/kg of body weight.
Participants 912 1034 3
megestrol acetate-treated patients reported appetite improvement and weight gain compared with dronabinol-treated patients
